DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

Sparano JA, Zhao F, Martino S et al.
Ten year update of E1199: phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in patients with axillary node-positive or high-risk node-negative breast cancer.

San Antonio Breast Cancer Symposium; 2014 S3-03

Download Bibliographical Data

Search in: